These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9479919)

  • 61. Liver magnetic resonance imaging: State of the art.
    Sijens PE
    World J Gastroenterol; 2010 Apr; 16(13):1558-9. PubMed ID: 20355233
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency.
    Dekkers IA; Roos R; van der Molen AJ
    Eur Radiol; 2018 Apr; 28(4):1579-1584. PubMed ID: 29063255
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Liver disease: imaging techniques and new therapies].
    Arbizu J; de la Cruz R; Garrastachu P; Mitjavila M
    Rev Esp Med Nucl; 2009; 28(3):135-57. PubMed ID: 19558957
    [No Abstract]   [Full Text] [Related]  

  • 64. Paramagnetic iron (III) MRI contrast agents.
    White DL
    Magn Reson Med; 1991 Dec; 22(2):309-12. PubMed ID: 1812362
    [No Abstract]   [Full Text] [Related]  

  • 65. Oral iron chelators: prospects for future development.
    Porter J
    Eur J Haematol; 1989 Oct; 43(4):271-85. PubMed ID: 2684681
    [No Abstract]   [Full Text] [Related]  

  • 66. Evidence for attachment of magnetic starch microspheres to Kupffer cells receptors in excised and perfused rat liver.
    Colet JM; Van Haverbeke Y; Muller RN
    Invest Radiol; 1994 Jun; 29 Suppl 2():S223-5. PubMed ID: 7928238
    [No Abstract]   [Full Text] [Related]  

  • 67. Gadolinium Deposition after Contrast-enhanced MR Imaging.
    Kanda T; Matsuda M; Oba H; Toyoda K; Furui S
    Radiology; 2015 Dec; 277(3):924-5. PubMed ID: 26599932
    [No Abstract]   [Full Text] [Related]  

  • 68. Superparamagnetic contrast agents for magnetic resonance imaging.
    Gundersen HG; Bach-Gansmo T; Holtz E; Fahlvik AK; Berg A
    Invest Radiol; 1990 Sep; 25 Suppl 1():S67-8. PubMed ID: 2283261
    [No Abstract]   [Full Text] [Related]  

  • 69. Using radiotracers to characterize magnetic resonance imaging contrast agents.
    Tweedle MF
    Invest Radiol; 2002 Mar; 37(3):107-13. PubMed ID: 11882789
    [No Abstract]   [Full Text] [Related]  

  • 70. Imaging the liver.
    Sahani DV; Kalva SP
    Oncologist; 2004; 9(4):385-97. PubMed ID: 15266092
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessing effective transvascular particle delivery to the brain parenchyma: a challenge to neuroradiology.
    Quencer RM
    AJNR Am J Neuroradiol; 1999 Feb; 20(2):186. PubMed ID: 10094333
    [No Abstract]   [Full Text] [Related]  

  • 72. Intracranial Deposition of Intravenous Gadolinium Contrast: A Literature Review.
    Franco J
    Radiol Technol; 2017 Mar; 88(4):435-439. PubMed ID: 28298504
    [No Abstract]   [Full Text] [Related]  

  • 73. Recognizing the Role of the Reticuloendothelial System in the Late Phase of US Contrast Agents.
    Khalili K; Atri M; Kim TK; Jang HJ
    Radiology; 2021 Feb; 298(2):287-291. PubMed ID: 33290174
    [No Abstract]   [Full Text] [Related]  

  • 74. Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride (DHOG-LE) for contrast-enhanced CT.
    Doerr-Stevens JK; Bakan DA; Lee FT; Chosy SG; Markhardt BK; Bonneville AK; Burrascano C; Delaney C; Longino MA; Greener Y; Weichert JP
    Acad Radiol; 2002 May; 9 Suppl 1():S200-4. PubMed ID: 12019869
    [No Abstract]   [Full Text] [Related]  

  • 75. Response.
    McDonald RJ; McDonald JS; Kallmes DF; Jentoft ME; Murray DL; Thielen KR; Williamson EE; Eckel LJ
    Radiology; 2015 Dec; 277(3):925. PubMed ID: 26929976
    [No Abstract]   [Full Text] [Related]  

  • 76. [Abdominal imaging].
    Siauve N; Coulon A
    J Radiol; 2005; 86(7-8):833-8. PubMed ID: 16342860
    [No Abstract]   [Full Text] [Related]  

  • 77. Nuclear magnetic resonance and the future of hepatology.
    Arias IM
    Hepatology; 1983; 3(5):763. PubMed ID: 6618440
    [No Abstract]   [Full Text] [Related]  

  • 78. Extracellular matrix gradients in the space of Disse: relevance to liver biology.
    Reid LM; Fiorino AS; Sigal SH; Brill S; Holst PA
    Hepatology; 1992 Jun; 15(6):1198-203. PubMed ID: 1592356
    [No Abstract]   [Full Text] [Related]  

  • 79. Quantitative MR Imaging Is Increasingly Important in Liver Disease.
    Boesch C
    Radiology; 2018 Feb; 286(2):557-559. PubMed ID: 29356638
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical implications of nuclear magnetic resonance lung research.
    Cutillo AG; Morris AH; Ailion DC; Durney CH
    Chest; 1989 Sep; 96(3):643-52. PubMed ID: 2670470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.